The anti-obesity effect of G-CSF is not associated with improved insulin resistance or glycemic control but is associated with increased energy expenditure and enhanced UCP-1 expression in BAT in a diabetic animal model. This evidence concerns the gene CSF3 and obesity due to melanocortin 4 receptor deficiency.